1st Dec 2025 14:20
(Sharecast News) - Ixico strengthened its scientific advisory board on Monday, with the appointment of two leading global authorities in Alzheimer's and cerebrovascular disease, bolstering its strategy to expand biomarker innovation in dementia research.
Read more17th Nov 2025 15:59
(Sharecast News) - Ixico announced on Monday that it has secured a new £3.5m contract to provide imaging services for a global phase three clinical trial in Huntington's disease, marking a significant commercial win for the neuroscience-focused biomarker analytics group.
Read more15th Oct 2025 11:58
(Sharecast News) - Ixico announced two new agreements worth a combined £1.2m on Wednesday, including a contract to support the validation of a diagnostic blood test and an extension to an existing Alzheimer's disease clinical trial.
Read more12th Aug 2025 14:09
(Sharecast News) - Ixico has secured two new clinical trial contracts in neurological disorders with a combined value of about £1.3m, it announced on Friday, extending its presence in both Alzheimer's disease and rare central nervous system conditions.
Read more17th Jul 2025 09:59
(Sharecast News) - Ixico said in an update on Thursday that it expects revenue for the financial year ending 30 September to be at least £6.3m, ahead of market expectations and representing a 9% increase from the prior year.
Read more12th Feb 2025 14:51
(Sharecast News) - Ixico announced further validation of its AI-driven imaging platform IXIQ.Ai in Huntington's disease (HD) research on Wednesday, through its collaboration with the Huntington's Disease Imaging Harmonisation (HD-IH) consortium.
Read more10th Dec 2024 10:45
(Sharecast News) - Neuroscience imaging firm Ixico has signed a contract with a new US-based client to provide imaging services for a Phase 2 Huntington's Disease clinical trial.
Read more14th Aug 2024 12:22
(Sharecast News) - Medical imaging advanced analytics technology company Ixico said in a trading update on Wednesday that it expected its financial performance to surpass market expectations, driven by new contract wins totaling £5.8m since 31 March.
Read more29th Jul 2024 12:02
(Sharecast News) - Medical imaging analytics specialist Ixico reported significant progress in its Huntington's disease imaging harmonisation (HD-IH) consortium on Monday.
Read more19th Jun 2024 10:35
(Sharecast News) - Precision analytics company Ixico announced a new contract valued at over £1m on Wednesday.
Read more15th Apr 2024 09:31
(Sharecast News) - Analytics company Ixico has inked a supply agreement with Life Molecular Imaging that will see it supply that latter's Neuraceq Amyloid PET tracer for use in pharma-sponsored clinical trials.
Read more13th Mar 2024 12:25
(Sharecast News) - Medical imaging analytics company Ixico said in a trading update on Wednesday that, despite ongoing progress in expanding its opportunities pipeline, the first half of 2024 had been marked by extended contracting cycles and delays in securing certain new contracts.
Read more12th Jan 2024 15:51
(Sharecast News) - Medical imaging analytics company Ixico announced on Friday that its chief executive officer Giulio Cerroni planned to retire from his position, and as a director, by the end of 2024.
Read more29th Sep 2023 13:08
(Sharecast News) - Advanced medical imaging analytics specialist Ixico said in an update on Friday that its earnings for the financial year would either meet or exceed market predictions, even though it faced a minor revenue shortfall.
Read more14th Jun 2023 14:17
(Sharecast News) - Medical imaging and analytics specialist Ixico has been awarded a new contract by an existing client, it announced on Wednesday, to provide imaging services for the extension study of their phase 2b trial for Huntington's disease (HD).
Read more